Avricore Health Inc (8VP1.SG)
Chart Events
Performance Outlook
| Previous Close | 0.2320 |
| Open | 0.2300 |
| Bid | 0.2260 x 0 |
| Ask | 0.2460 x 0 |
| Day's Range | 0.2300 - 0.2460 |
| 52 Week Range | 0.0455 - 0.2760 |
| Volume | |
| Avg. Volume | 390 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Nov 29, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 8VP1.SG
Related Research
- News Direct
Avricore Health looks to continue positive growth in 2023 after success in 2022
Avricore Health CEO Hector Bremner joined Proactive's Steve Darling with an update on the company's 2022 performance and the goals it has set for 2023.
- GlobeNewswire
Avricore Health Corporate Update – Earnings Advisory 2022 and 2023 Objectives
VANCOUVER, British Columbia, Feb. 01, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As part of this effort the Company is pleased to provide insight into the successes of last year and lay out updates and objectives on further progress. “Last year we set out bold targe
- GlobeNewswire
Avricore Health Reports Third-Quarter 2022 Results
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives. The Company’s objective to create the world’s first cloud-connected point-of-care network in community pharmacy is on track to becoming a reality, bringing powerful health screening and data management tools to community pha
